BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao P, Cheng J, Li B, Nie D, Li C, Gui S, Wang H, Zhang Y. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas. Cell Biol Toxicol 2021;37:633-51. [PMID: 33400021 DOI: 10.1007/s10565-020-09570-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gil J, Jordà M, Soldevila B, Puig-Domingo M. Epithelial-Mesenchymal Transition in the Resistance to Somatostatin Receptor Ligands in Acromegaly. Front Endocrinol (Lausanne) 2021;12:646210. [PMID: 33790868 DOI: 10.3389/fendo.2021.646210] [Reference Citation Analysis]
2 Donati S, Aurilia C, Palmini G, Miglietta F, Falsetti I, Iantomasi T, Brandi ML. MicroRNAs as Potential Biomarkers in Pituitary Adenomas. Noncoding RNA 2021;7:55. [PMID: 34564317 DOI: 10.3390/ncrna7030055] [Reference Citation Analysis]
3 Aydin B, Caliskan A, Arga KY. Overview of omics biomarkers in pituitary neuroendocrine tumors to design future diagnosis and treatment strategies. EPMA J 2021;12:383-401. [PMID: 34567287 DOI: 10.1007/s13167-021-00246-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gareev I, Beylerli O, Liang Y, Xiang H, Liu C, Xu X, Yuan C, Ahmad A, Yang G. The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors. Front Cell Dev Biol 2021;9:740303. [PMID: 34692698 DOI: 10.3389/fcell.2021.740303] [Reference Citation Analysis]